Over the last four years the NHS Innovation Challenge Prizes have helped to identify and spread proven innovations, promoting a culture of invention and driving adoption of the best ideas.
This year, Alere was recognized when Liz Cross, Nurse Practitioner, and Dr. David Zimmel, GP, both from Attenborough Surgery in Watford, were one of 4 winners of the Acorn Challenge Prize, an open innovation fund, for which they were awarded £10,000 for their work using Alere™ Afinion CRP in their GP practice to help reduce prescribing rates and re-attendances.
Ms. Cross told GP Magazine, “I was kind of expecting [antibiotic prescribing to drop], but the most interesting part for me was if I don’t prescribe antibiotics – last winter, if I didn’t prescribe antibiotics when patients came in with their chesty coughs, a quarter would come back and they would present to a GP, out-of-hours, or A&E."
"And now, if I don’t prescribe and have done the CRP test, 4% come back. So my re-attendance rates are really reduced and my cost savings are through that. I save about £100 a month, after paying for the tests, on prescribing and reduced follow up appointments. It doesn't sound much but it means the project is sustainable and patients get better quality care.”1
All entries were judged by an Expert Panel, consisting of some of the England’s most senior healthcare leaders and innovators. Aligned to the NHS Outcomes Framework – 5 domains resources, the panel looked for innovations that can demonstrate:
- Improved outcomes for patients and better value for money
- New models of delivering care that flexible and responsive to the needs of local communities
- Innovative ways of harnessing the coming innovations in modern medicine
- Personalised services that reflect the needs and expectations of patients and their families
The prize had over 400 expressions of interest, 215 final applicants and 4 judging panels.
To learn more about the NHS Innovation Challenge Prizes, visit their website.
Explore TestTargetTreat.com to learn more about rapid diagnostic solutions from Alere and their role in antimicrobial stewardship.